Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Feb 29, 2008 at 3:15 PM EST

Applera & Celera Separation, For Real This Time (ABI, CRA)

Applera Corporation had an SEC Filing today saying its Board of Directors has authorized management to pursue a possible separation…

Douglas A. McIntyre | Feb 28, 2008 at 9:20 AM EST

CardioNet Sets IPO Terms (BEAT, SIVB)

CardioNet, Inc. has set the terms for its IPO in an amended SEC filing. The systems provider for monitoring real-time…

Douglas A. McIntyre | Feb 27, 2008 at 5:44 AM EST

Amgen (AMGN) And Johnson & Johnson (JNJ): When The Patients Die

Two of the best-selling drugs in the US are Procrit from Johnson & Johnson (NYSE: JNJ) and Aranesp from Amgen…

Douglas A. McIntyre | Feb 26, 2008 at 5:57 PM EST

S&P Index Change for West Pharmaceutical Services (WST, UNH, SIE)

We do not cover every single index change, but we do cover the ones where it looks like it will…

Douglas A. McIntyre | Feb 26, 2008 at 10:55 AM EST

Prana Soars On Alzheimer’s Results (PRAN)

A small biotech out of Australia called Prana Biotechnology Ltd. (NASDAQ: PRAN) today is trading up nearly 50% to a…

Douglas A. McIntyre | Feb 22, 2008 at 12:39 PM EST

IPO Withdrawal: Transoma Medical (TSMA)

Transoma Medical, Inc. withdrew its IPO filing this morning, citing “unfavorable market conditions.” The company originally filed its IPO paperwork…

Douglas A. McIntyre | Feb 22, 2008 at 8:52 AM EST

Melanoma Patients Have Another Hope With New Orphan Drug Designation (ADH, MEDX)

Adherex Technologies Inc. (AMEX: ADH) has announced that it has received an orphan drug designation for its ADH-1 from the…

Douglas A. McIntyre | Feb 21, 2008 at 10:11 AM EST

Teva’s Lofty Goals Seem Attainable (TEVA)

Teva Pharmaceutical (NASDAQ: TEVA – News) has some pretty loft goals for itself at its Investor Day presentation. If you…

Douglas A. McIntyre | Feb 20, 2008 at 1:13 PM EST

Major Biotech Movers (AGEN, CEGE, ENCY, IDMI, IMCL, ONXX, PFE, NTII, OXGN, PSDV, SIRT)

Antigenics Inc. (NASDAQ: AGEN) A study for Cancer vaccine, Oncophage, for the treatment of metastatic melanoma showed mixed results this…

Douglas A. McIntyre | Feb 16, 2008 at 11:06 AM EST

US Drugs: A “Made In China” Label (BAX)

The uproar about Heparin, a widely-used drug marketed by Baxter International (NYSE: BAX), is just beginning. As The Wall Street…

Douglas A. McIntyre | Feb 14, 2008 at 8:38 AM EST

TorreyPines Therapeutics: Forget Morale, The Beatings Continue (TPTX)

TorreyPines Therapeutics (NASDAQ: TPTX) has announced its strategic plan for 2008. Unfortunately it doesn’t look or sound very promising. The…

Douglas A. McIntyre | Feb 14, 2008 at 8:10 AM EST

Genoptix Insiders & Backers Cutting Stake in Secondary Offering (GXDX)

The venture backers and the officers and insiders Genoptix (NASDAQ: GXDX) have filed to sell 4.2 million shares of common…

Douglas A. McIntyre | Feb 13, 2008 at 6:57 PM EST

Baxter (BAX) Bleeds Patients Further

Heparin, made Baxter International (NYSE: BAX) is one of the most widely used blood thinners in the world. Today’s disclosure…

Douglas A. McIntyre | Feb 13, 2008 at 5:12 PM EST

Oculus Files To Sell More Securities Than Its Market Cap (OCLS)

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) has just filed a shelf registration that would allow the company to sell up…

Douglas A. McIntyre | Feb 13, 2008 at 3:34 PM EST

Dendreon Shares Losing House Committee Hope (DNDN)

CNBC’s Mike Huckman just announced what is going to be a disappointment for Dendreon (NASDAQ: DNDN) holders, and that may…

1 … 356 357 358 359 360 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Applera & Celera Separation, For Real This Time (ABI, CRA)

CardioNet Sets IPO Terms (BEAT, SIVB)

Amgen (AMGN) And Johnson & Johnson (JNJ): When The Patients Die

S&P Index Change for West Pharmaceutical Services (WST, UNH, SIE)

Prana Soars On Alzheimer’s Results (PRAN)

IPO Withdrawal: Transoma Medical (TSMA)

Melanoma Patients Have Another Hope With New Orphan Drug Designation (ADH, MEDX)

Teva’s Lofty Goals Seem Attainable (TEVA)

Major Biotech Movers (AGEN, CEGE, ENCY, IDMI, IMCL, ONXX, PFE, NTII, OXGN, PSDV, SIRT)

US Drugs: A “Made In China” Label (BAX)

TorreyPines Therapeutics: Forget Morale, The Beatings Continue (TPTX)

Genoptix Insiders & Backers Cutting Stake in Secondary Offering (GXDX)

Baxter (BAX) Bleeds Patients Further

Oculus Files To Sell More Securities Than Its Market Cap (OCLS)

Dendreon Shares Losing House Committee Hope (DNDN)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

Applera & Celera Separation, For Real This Time (ABI, CRA)

CardioNet Sets IPO Terms (BEAT, SIVB)

Amgen (AMGN) And Johnson & Johnson (JNJ): When The Patients Die

S&P Index Change for West Pharmaceutical Services (WST, UNH, SIE)

Prana Soars On Alzheimer’s Results (PRAN)

IPO Withdrawal: Transoma Medical (TSMA)

Melanoma Patients Have Another Hope With New Orphan Drug Designation (ADH, MEDX)

Teva’s Lofty Goals Seem Attainable (TEVA)

Major Biotech Movers (AGEN, CEGE, ENCY, IDMI, IMCL, ONXX, PFE, NTII, OXGN, PSDV, SIRT)

US Drugs: A “Made In China” Label (BAX)

TorreyPines Therapeutics: Forget Morale, The Beatings Continue (TPTX)

Genoptix Insiders & Backers Cutting Stake in Secondary Offering (GXDX)

Baxter (BAX) Bleeds Patients Further

Oculus Files To Sell More Securities Than Its Market Cap (OCLS)

Dendreon Shares Losing House Committee Hope (DNDN)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%